Welcome to The Pharmacogenomics Journal
The Pharmacogenomics Journal is dedicated to the rapid publication of original research on basic pharmacogenomics research and its clinical applications. Publishing six times a year, the journal aims to provide the highest caliber of coverage concerning the effects of genetic variablity on drug toxicity and efficacy, the characterization of polymorphisms relevant to drug action, and the identification of novel genomic targets for drug development.
*** Announcing The Pharmacogenomics Journal Open ***
The Pharmacogenomics Journal now offers authors the option to publish their articles with immediate open access upon publication. Open access articles will also be deposited on PubMed Central at the time of publication and will be freely available immediately. Find out more from the press release or our FAQs page.
******
Free online issue
Volume 9, No 3
June 2009
ISSN: 1470-269X
EISSN: 1473-1150
Impact Factor 5.435*
Editor:
Julio Licinio, MD
*2008 Journal Citation Report (Thomson Reuters, 2009)
FEATURED ARTICLES
REVIEW
Genetic alterations in CRC FREEORIGINAL ARTICLE
TNF-
-308 G/A variant and anti-TNF- agents
FREE ORIGINAL ARTICLE
Study of TD and DRD4 gene in schizophrenia patients FREEORIGINAL ARTICLE
GNAS1 T393C polymorphism and esophageal cancer FREENEWS
Visit The Pharmacogenomics Journal Blog and keep up with the latest research in the field!
Disease complexity and drug safety. Using Alzheimer's disease as a model of tackling complex pharmacogenetics issues, a review article by Roses et al. discusses how pharmacogenetics affects pipelines and phases of drug development.
-
Research and Reviews
Latest research highlights and reviews from the NPG family of journals
